NCT06628739View on ClinicalTrials.gov

Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes

CompletedOBSERVATIONAL
Enrollment

168

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

June 30, 2022

Study Completion Date

May 31, 2023

Conditions
Gastrointestinal Stromal Tumor, Malignant
Interventions
DRUG

Imatinib

The long-term maintenance dose of every patient was determined by the physician based on the guidelines and the patients' individual conditions such as adverse reactions.

Trial Locations (1)

Unknown

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT06628739 - Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes | Biotech Hunter | Biotech Hunter